Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)

Bai Liang He; Ning Yang; Cheuk Him Man; Nelson Ka Lam Ng; Chae Yin Cher; Ho Ching Leung; Leo Lai Hok Kan; Bowie Yik Ling Cheng; Stephen Sze Yuen Lam; Michelle Lu Lu Wang; Chun Xiao Zhang; Hin Kwok; Grace Cheng; Rakesh Sharma; Alvin Chun Hang Ma; Chi Wai Eric So; Yok Lam Kwong; Anskar Yu Hung Leung

doi:10.15252/emmm.202012911

Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)

Bai Liang He, Ning Yang, Cheuk Him Man, Nelson Ka Lam Ng, Chae Yin Cher, Ho Ching Leung, Leo Lai Hok Kan, Bowie Yik Ling Cheng, Stephen Sze Yuen Lam, Michelle Lu Lu Wang, Chun Xiao Zhang, Hin Kwok, Grace Cheng, Rakesh Sharma, Alvin Chun Hang Ma, Chi Wai Eric So, Yok Lam Kwong, Anskar Yu Hung Leung

Research output: Journal article publication › Comment/debate/erratum

2 Citations (Scopus)

Original language	English
Article number	e12911
Journal	EMBO Molecular Medicine
Volume	12
Issue number	8
DOIs	https://doi.org/10.15252/emmm.202012911
Publication status	Published - 7 Aug 2020

ASJC Scopus subject areas

Molecular Medicine

More information

10.15252/emmm.202012911

Cite this

He, B. L., Yang, N., Man, C. H., Ng, N. K. L., Cher, C. Y., Leung, H. C., Kan, L. L. H., Cheng, B. Y. L., Lam, S. S. Y., Wang, M. L. L., Zhang, C. X., Kwok, H., Cheng, G., Sharma, R., Ma, A. C. H., So, C. W. E., Kwong, Y. L., & Leung, A. Y. H. (2020). Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895). EMBO Molecular Medicine, 12(8), Article e12911. https://doi.org/10.15252/emmm.202012911

@article{64640c96abb14ae2836fbe60e8643580,

title = "Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)",

author = "He, {Bai Liang} and Ning Yang and Man, {Cheuk Him} and Ng, {Nelson Ka Lam} and Cher, {Chae Yin} and Leung, {Ho Ching} and Kan, {Leo Lai Hok} and Cheng, {Bowie Yik Ling} and Lam, {Stephen Sze Yuen} and Wang, {Michelle Lu Lu} and Zhang, {Chun Xiao} and Hin Kwok and Grace Cheng and Rakesh Sharma and Ma, {Alvin Chun Hang} and So, {Chi Wai Eric} and Kwong, {Yok Lam} and Leung, {Anskar Yu Hung}",

year = "2020",

month = aug,

day = "7",

doi = "10.15252/emmm.202012911",

language = "English",

volume = "12",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "Springer",

number = "8",

}

He, BL, Yang, N, Man, CH, Ng, NKL, Cher, CY, Leung, HC, Kan, LLH, Cheng, BYL, Lam, SSY, Wang, MLL, Zhang, CX, Kwok, H, Cheng, G, Sharma, R, Ma, ACH, So, CWE, Kwong, YL & Leung, AYH 2020, 'Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)', EMBO Molecular Medicine, vol. 12, no. 8, e12911. https://doi.org/10.15252/emmm.202012911

TY - JOUR

T1 - Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)

AU - He, Bai Liang

AU - Yang, Ning

AU - Man, Cheuk Him

AU - Ng, Nelson Ka Lam

AU - Cher, Chae Yin

AU - Leung, Ho Ching

AU - Kan, Leo Lai Hok

AU - Cheng, Bowie Yik Ling

AU - Lam, Stephen Sze Yuen

AU - Wang, Michelle Lu Lu

AU - Zhang, Chun Xiao

AU - Kwok, Hin

AU - Cheng, Grace

AU - Sharma, Rakesh

AU - Ma, Alvin Chun Hang

AU - So, Chi Wai Eric

AU - Kwong, Yok Lam

AU - Leung, Anskar Yu Hung

PY - 2020/8/7

Y1 - 2020/8/7

UR - http://www.scopus.com/inward/record.url?scp=85089035506&partnerID=8YFLogxK

U2 - 10.15252/emmm.202012911

DO - 10.15252/emmm.202012911

M3 - Comment/debate/erratum

C2 - 32767634

AN - SCOPUS:85089035506

SN - 1757-4676

VL - 12

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

IS - 8

M1 - e12911

ER -

Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)

ASJC Scopus subject areas

More information

Other files and links

Cite this